Zein Youssef El's Form 4 filing
Aceragen, Inc. (ACGN) · filed Jul 19, 2023
- Accession no.
- 0000899243-23-017445
- Filed
- Jul 19, 2023, 4:05 PM ET
- Trade date
- Jul 12-13, 2023
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $9.10K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zein Youssef ElCIK 0001193366 | 10% Owner |
| Pillar Invest CorpCIK 0001534428 | 10% Owner |
| Umari AbudeCIK 0001783582 | 10% Owner |
| Pillar Partners Foundation, L.P.CIK 0001783583 | 10% Owner |
| Pillar Pharmaceuticals 6, L.P.CIK 0001783584 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2023 | Common Stock | SSaleDisposed | −3,605 | $1.58 | −$5,695.9 | 167,107 | Indirect | |
| Jul 13, 2023 | Common Stock | SSaleDisposed | −2,213 | $1.54 | −$3,408.02 | 164,894 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Mr. Umari's 29,965 shares of the Issuer's Common Stock purchased on May 17, 2023 are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with Mr. Umari's sales of 3,605 shares of the Issuer's Common Stock on July 12, 2023 and of 2,213 shares of the Issuer's Common Stock on July 13, 2023. Mr. Umari has made arrangements with the Issuer to voluntarily disgorge $842.36 to the Issuer, which represents the full amount of Mr. Umari's short-swing profit realized from the matchable transactions as calculated pursuant to Section 16(b).